Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
- 期刊名称OncoTargets and Therapy
- 作者Wang, Yong; Meng, Xiangji; Zhou, Shizhen; Zhu, Yufang; Xu, Jun; Tao, Rongjie
- 电子ISSN1178-6930
- 文件大小2312.50KB
- 发表时间2019-12
- DOI10.2147/OTT.S226804
- 页码10579-10585
Bystander signaling via oxidative metabolismSawal, Humaira; Asghar, Kashif; Bureik, Matthias; Jalal, Nasir · OncoTargets and Therapy · 2017
Arterial stiffness in hematologic malignanciesMozos, Ioana; Borzak, Georgiana; Caraba, Alexandru; Mihaescu, Rodica · OncoTargets and Therapy · 2017
Intrahepatic cholangiocarcinoma: current perspectivesBuettner, Stefan; van Vugt, Jeroen L.A.; IJzermans, Jan; Groot Koerkamp, Bas · OncoTargets and Therapy · 2017
Ganetespib: research and clinical developmentModi, Shanu; Jhaveri, Komal · OncoTargets and Therapy · 2015
Primary effusion lymphoma: current perspectivesNarkhede, Mayur; Arora, Shagun; Ujjani, Chaitra · OncoTargets and Therapy · 2018
ArrayWang, Xuanxuan; Gu, Yanjun; Liu, Hai; Shi, Liming; Sun, Xiaonan · OncoTargets and Therapy · 2018
Adenosquamous carcinoma of the lungLi, Chenghui; Lu, Hongyang · OncoTargets and Therapy · 2018
RetractionHill, Tim · OncoTargets and Therapy · 2016